Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
A major new review published in BJU International explores additional treatments and lifestyle measures for men with early prostate cancer who are managed with active surveillance, as well as monitoring tools that may help guide care.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
File results
-
FOI/2023/0651 - Professional nurse advocate
-
FOI/2023/0653 - Telecommunication pay as you go contract
-
FOI/2023/0654 - Email encryption/ E-signature suppliers
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0658 - Policies/procedures for Non-emergency patient transport services
-
FOI/2023/0662 - NEPTS and patient transport services
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage